Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Varone

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Neurology|May 22, 2025
Spinal muscular atrophy in the era of newborn screening: how the classification could changeAntonio Varone, Gabriella Esposito, Ilaria Bitetti
Gene Therapy|May 23, 2022
Onasemnogene abeparvovec gene replacement therapy for the treatment of spinal muscular atrophy: a real-world observational studyIlaria Bitetti, Valentina Lanzara, Giovanna Margiotta, et al.
International Journal of Neonatal Screening|March 27, 2026
Clinical Experience of Timing Treatment in Newborns with Spinal Muscular Atrophy: A Call for Standardized Screening Practices in ItalyIlaria Bitetti, Rosa Iannaccone, Giovanna Margiotta, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|December 13, 2023
Sequential treatment with nusinersen, Zolgensma<sup>®</sup> and risdiplam in a paediatric patient with spinal muscular atrophytype 1: a case reportIlaria Bitetti, Maria Rosaria Manna, Roberto Stella, et al.
Frontiers in Neurology|March 7, 2024
Motor and neurocognitive profiles of children with symptomatic spinal muscular atrophy type 1 with two copies of <i>SMN2</i> before and after treatment: a longitudinal observational studyIlaria Bitetti, Maria Rosaria Manna, Roberto Stella, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 1, 2021
Clinical presentation of a stroke-like episode in MELAS syndrome: what is the impact of epileptogenic activity?Pia Bernardo, Maria Pandolfi, Paola Vedova, et al.
Pediatric Radiology|April 25, 2026
Brain magnetic resonance imaging markers of vigabatrin-associated neurotoxicity during hyperpyrexia-triggered focal status epilepticus: cause or coincidence?Gabriella Errichiello, Mario Tortora, Adriana Cristofano, et al.
Acta Neurochirurgica|November 8, 2025
How I do it: continuous intraventricular interferon alpha infusion in pediatric patients with subacute sclerosing panencephalitisFrancesco Tengattini, Gabriella Errichiello, Antonio Varone, et al.
Macromolecular Bioscience|June 4, 2014
Bioengineered silk gene delivery system for nuclear targetingSezin Yigit, Olena Tokareva, Antonio Varone, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|January 20, 2022
Early treatment with Ataluren of a 2-year-old boy with nonsense mutation Duchenne dystrophyIlaria Bitetti, Cinzia Mautone, Marianna Bertella, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Neurology|May 22, 2025
Spinal muscular atrophy in the era of newborn screening: how the classification could changeAntonio Varone, Gabriella Esposito, Ilaria Bitetti
Gene Therapy|May 23, 2022
Onasemnogene abeparvovec gene replacement therapy for the treatment of spinal muscular atrophy: a real-world observational studyIlaria Bitetti, Valentina Lanzara, Giovanna Margiotta, et al.
International Journal of Neonatal Screening|March 27, 2026
Clinical Experience of Timing Treatment in Newborns with Spinal Muscular Atrophy: A Call for Standardized Screening Practices in ItalyIlaria Bitetti, Rosa Iannaccone, Giovanna Margiotta, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|December 13, 2023
Sequential treatment with nusinersen, Zolgensma<sup>®</sup> and risdiplam in a paediatric patient with spinal muscular atrophytype 1: a case reportIlaria Bitetti, Maria Rosaria Manna, Roberto Stella, et al.
Frontiers in Neurology|March 7, 2024
Motor and neurocognitive profiles of children with symptomatic spinal muscular atrophy type 1 with two copies of <i>SMN2</i> before and after treatment: a longitudinal observational studyIlaria Bitetti, Maria Rosaria Manna, Roberto Stella, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 1, 2021
Clinical presentation of a stroke-like episode in MELAS syndrome: what is the impact of epileptogenic activity?Pia Bernardo, Maria Pandolfi, Paola Vedova, et al.
Pediatric Radiology|April 25, 2026
Brain magnetic resonance imaging markers of vigabatrin-associated neurotoxicity during hyperpyrexia-triggered focal status epilepticus: cause or coincidence?Gabriella Errichiello, Mario Tortora, Adriana Cristofano, et al.
Acta Neurochirurgica|November 8, 2025
How I do it: continuous intraventricular interferon alpha infusion in pediatric patients with subacute sclerosing panencephalitisFrancesco Tengattini, Gabriella Errichiello, Antonio Varone, et al.
Macromolecular Bioscience|June 4, 2014
Bioengineered silk gene delivery system for nuclear targetingSezin Yigit, Olena Tokareva, Antonio Varone, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|January 20, 2022
Early treatment with Ataluren of a 2-year-old boy with nonsense mutation Duchenne dystrophyIlaria Bitetti, Cinzia Mautone, Marianna Bertella, et al.
Pageof 5